🇮🇳IN
Sign In
GV

GVBL

BSE

Genomic Valley Biotech Ltd

₹48.01

-1.99(-3.98%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

GVBL valuation summary

Genomic Valley Biotech Ltd trades at 1048.0 times trailing earnings. Return on equity is 0.8% and return on capital employed is 1.0%. That P/E equals an earnings yield of 0.1%. The median P/E across 22 listed Biotechnology companies is 48.0, so Genomic Valley Biotech Ltd trades at a 1566% premium to that median.

P/E1048.0
ROE0.8%
ROCE1.0%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer